Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126555692 | 12655569 | 2 | F | 20160822 | 20160816 | 20160831 | EXP | US-SA-2016SA145156 | AVENTIS | 0.00 | A | M | Y | 81.65000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126555692 | 12655569 | 1 | PS | LANTUS | INSULIN GLARGINE | 1 | Unknown | U | UNKNOWN | 21081 | |||||||||
126555692 | 12655569 | 2 | SS | NOVOLOG | INSULIN ASPART | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
126555692 | 12655569 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
126555692 | 12655569 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | LAST DOSE WAS IN 2010 OR 2011 | 0 | 1 | DF | CAPSULE | TID | ||||||
126555692 | 12655569 | 5 | C | NEURONTIN | GABAPENTIN | 1 | Oral | LAST DOSE WAS IN 2010 OR 2011 | 0 | 1 | DF | CAPSULE | TID | ||||||
126555692 | 12655569 | 6 | C | LYRICA | PREGABALIN | 1 | Oral | TWICE A DAY AS NEEDED?START DATE: AROUND 2009 OR 2010. | L61961 | 0 | 1 | DF | CAPSULE | ||||||
126555692 | 12655569 | 7 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | TWO TIMES A DAY AS NEEDED?START DATE: ABOUT 20 OR 30 YEARS AGO | 0 | 1 | DF | TABLET | |||||||
126555692 | 12655569 | 8 | C | DOLOPHINE | METHADONE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
126555692 | 12655569 | 9 | C | DOLOPHINE | METHADONE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
126555692 | 12655569 | 10 | C | DOLOPHINE | METHADONE HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | TABLET | TID | |||||||
126555692 | 12655569 | 11 | C | DOLOPHINE | METHADONE HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | TABLET | TID | |||||||
126555692 | 12655569 | 12 | C | HCG | GONADOTROPHIN, CHORIONIC | 1 | 0 | ||||||||||||
126555692 | 12655569 | 13 | C | XANAX | ALPRAZOLAM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126555692 | 12655569 | 2 | Diabetes mellitus |
126555692 | 12655569 | 4 | Diabetic neuropathy |
126555692 | 12655569 | 5 | Diabetic neuropathy |
126555692 | 12655569 | 6 | Diabetic neuropathy |
126555692 | 12655569 | 8 | Pancreatitis chronic |
126555692 | 12655569 | 9 | Pain |
126555692 | 12655569 | 10 | Pancreatitis chronic |
126555692 | 12655569 | 11 | Pain |
126555692 | 12655569 | 12 | Hypothalamo-pituitary disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126555692 | 12655569 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126555692 | 12655569 | Diabetic ketoacidosis | |
126555692 | 12655569 | Glycosylated haemoglobin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126555692 | 12655569 | 8 | 1990 | 0 | ||
126555692 | 12655569 | 9 | 1990 | 0 |